Lataa...
Prevention of cisplatin-induced hearing loss by extended release fluticasone propionate intracochlear implants
OBJECTIVE: Cisplatin is a chemotherapeutic drug known to induce hearing loss. Although corticosteroids may help to mitigate the ototoxic side effects of cisplatin, there are complications associated with their systemic and prolonged use. The goal of this study is to test the efficacy of extended-rel...
Tallennettuna:
| Julkaisussa: | Int J Pediatr Otorhinolaryngol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6502669/ https://ncbi.nlm.nih.gov/pubmed/30913504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijporl.2019.03.021 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|